Result:Good· Market: UpTurnaroundMargin expansion
| Metric | Value | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 1.2K Cr | 10.6% | 12.7% |
| Total Income | 1.3K Cr | 9.5% | 12.5% |
| Expenditure | 1.1K Cr | 0.6% | 3.5% |
| PBT | 110.04 Cr | 1222.6% | 1052.3% |
| Net Profit | 54.98 Cr | 267.0% | 499.0% |
| OPM | 17.81% | 8.04pp | 7.26pp |
| NPM | 4.39% | 3.08pp | 5.63pp |
| EPS | 7.49 | 267.2% | 298.4% |
Chemicals: revenue grew a healthy 12.6% YoY alongside a loss-to-profit turnaround with OPM up sharply from 10.55% to 17.81%, driven by core operations rather than a one-off, though the tiny prior-year base tempers a very_good call.
Informational and educational content only. Not investment advice.